Merck’s Vioxx Replacement Still A Heart Risk

Merck’s getting in on the arthritis market again with a new drug, called Arcoxia. You might remember their previous offering, Vioxx, which was discontinued two years ago after octogenarians countrywide lifted their contorted, claw-like hands to a withered chest and let out a rattling gasp under the influence of a massive, Vioxx-induced heart attack. Lawsuits abounded.